Molecular Characterization of ANKTM1
ANKTM1 的分子表征
基本信息
- 批准号:7069145
- 负责人:
- 金额:$ 5.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The broad objective of this proposal is to contribute to our understanding of how we perceive our environment. Specifically, I will be examining the systems that facilitate our perception of temperature and pan. Recently, numerous members of the TRP-family of non-specific cation channels (TRPc) have been shown to be activated in response to different ranges of temperature. TRPV1, the first thermo sensitive TRPc identified, is activated by noxious heat and has a demonstrated role in inflammation induced thermal hyperalgesia. The molecular mechanisms by which TRPcs are activated by temperature are currently unknown. ANKTM1, a putative polymodal nociceptor was recently identified as a TRP channel that responds to noxious levels of cold, the noxious compound cinnamaldehyde, the inflammatory peptide brandykinin when co-expressed with the brandykinin receptor and is expressed in a subset of nociceptive sensory neurons. The goals of this proposal are to identify specific residues/domains within ANKTM1 that confer the ability to sense noxious cold and/or cinnamaldehyde. The findings from these studies will provide a basic understanding of the mechanisms of ANKTM1 activation and may provide general insight into how temperature gates TRP channel activation. This research may also contribute to the development of therapeutic drugs to manage pain based on the identification of potential targets on the nociceptor, ANKTM1
描述(由申请人提供):本提案的广泛目标是帮助我们了解我们如何看待我们的环境。具体来说,我将研究促进我们对温度和锅的感知的系统。最近,非特异性阳离子通道(TRPc)的TRP家族的许多成员已被证明在不同的温度范围内被激活。TRPV 1是第一个被发现的热敏性TRPc,被有害热激活,并在炎症诱导的热痛觉过敏中发挥作用。TRPcs被温度激活的分子机制目前尚不清楚。ANKTM 1是一种假定的多模态伤害感受器,最近被鉴定为TRP通道,当与布兰迪激肽受体共表达时,其响应于有害水平的冷、有害化合物肉桂醛、炎性肽布兰迪激肽,并且在伤害感受感觉神经元的子集中表达。该提议的目标是鉴定ANKTM 1内赋予感测有害冷和/或肉桂醛的能力的特定残基/结构域。这些研究的结果将提供对ANKTM 1激活机制的基本理解,并可能提供对温度门控TRP通道激活的一般见解。这项研究也可能有助于开发基于伤害感受器ANKTM 1上潜在靶点的治疗药物来管理疼痛。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AJAY K DHAKA其他文献
AJAY K DHAKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AJAY K DHAKA', 18)}}的其他基金
Identifying new targets in pain, utilizing the novel analgesic AS1
利用新型镇痛药 AS1 确定疼痛的新靶点
- 批准号:
10307581 - 财政年份:2020
- 资助金额:
$ 5.04万 - 项目类别:
Identifying new targets in pain, utilizing the novel analgesic AS1
利用新型镇痛药 AS1 确定疼痛的新靶点
- 批准号:
10547775 - 财政年份:2020
- 资助金额:
$ 5.04万 - 项目类别:
Identifying new targets in pain, utilizing the novel analgesic AS1
利用新型镇痛药 AS1 确定疼痛的新靶点
- 批准号:
10117446 - 财政年份:2020
- 资助金额:
$ 5.04万 - 项目类别:
A Highthroughput Targeted Genetic Screen for Modulators of Nociception
伤害感受调节剂的高通量靶向遗传筛选
- 批准号:
9582710 - 财政年份:2018
- 资助金额:
$ 5.04万 - 项目类别:
An unbiased highthroughput behavior based screen for small molecule analgesics
基于无偏倚高通量行为的小分子镇痛药筛选
- 批准号:
9241451 - 财政年份:2016
- 资助金额:
$ 5.04万 - 项目类别:
An unbiased highthroughput behavior based screen for small molecule analgesics
基于无偏倚高通量行为的小分子镇痛药筛选
- 批准号:
9090664 - 财政年份:2016
- 资助金额:
$ 5.04万 - 项目类别:
相似海外基金
Architecture, dynamics and regulation of erythrocyte ankyrin-1 complexes
红细胞ankyrin-1复合物的结构、动力学和调节
- 批准号:
10638440 - 财政年份:2023
- 资助金额:
$ 5.04万 - 项目类别:
Molecular mechanisms of spectrin-dependent axonal organization and function in cerebellar granule cells
小脑颗粒细胞血影蛋白依赖性轴突组织和功能的分子机制
- 批准号:
10605465 - 财政年份:2023
- 资助金额:
$ 5.04万 - 项目类别:
Neuroresilience to hyper-gravity and desiccation in tardigrade Hypsibius exemplaris
缓步动物 Hypsibius exemplaris 对超重力和干燥的神经弹性
- 批准号:
10607915 - 财政年份:2023
- 资助金额:
$ 5.04万 - 项目类别:
Structural and Functional Synthetic Proteomimetics of Ankyrin Repeat Proteins
锚蛋白重复蛋白的结构和功能合成蛋白质模拟
- 批准号:
10537913 - 财政年份:2022
- 资助金额:
$ 5.04万 - 项目类别:
Mechanism of a Male Killing Toxin in a Drosophila endosymbiont
果蝇内共生体中雄性致死毒素的机制
- 批准号:
10609906 - 财政年份:2022
- 资助金额:
$ 5.04万 - 项目类别:
Mechanism of a Male Killing Toxin in a Drosophila endosymbiont
果蝇内共生体中雄性致死毒素的机制
- 批准号:
10432565 - 财政年份:2022
- 资助金额:
$ 5.04万 - 项目类别:
Structure-function analysis of a catalase/ankyrin tandem from Pseudomonas aeruginosa necessary for resistance to hydrogen peroxide
铜绿假单胞菌过氧化氢酶/锚蛋白串联的结构-功能分析对于抵抗过氧化氢是必需的
- 批准号:
10598215 - 财政年份:2022
- 资助金额:
$ 5.04万 - 项目类别:
The Molecular Architecture of Axons in Health and Disease
健康和疾病中轴突的分子结构
- 批准号:
10406278 - 财政年份:2021
- 资助金额:
$ 5.04万 - 项目类别:
Convergent mechanisms for neurodevelopmental disorder genes
神经发育障碍基因的趋同机制
- 批准号:
10405021 - 财政年份:2021
- 资助金额:
$ 5.04万 - 项目类别: